Andere Sprachen Ginkgo Bioworks Holdings, Inc.

Aktien

A3C3B4

US37611X1000

DNA

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 24.04.2024			% 5 Tage	% 1. Jan.
0.8458 ^USD	-2.84%		-2.96%	-49.95%

16.04.	Il Granaio delle Idee und Ginkgo Bioworks kündigen strategische Zusammenarbeit zur Optimierung von Sauerteigstämmen für Backwaren an	CI
11.04.	Transcript : Ginkgo Bioworks Holdings, Inc. Presents at Ginkgo's Annual Ferment Conference 2024, Apr-11-2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Global Retail Giant Enhances Warehouse Efficiency with Vuzix (VUZI) Smart Glasses Rollout	24.04.
Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products	16.04.
Il Granaio delle Idee and Ginkgo Bioworks Announces Strategic Collaboration to Optimize Sourdough Strains for Bakery Products	16.04.
Modalis Announces Partnership with Ginkgo Bioworks	15.04.
Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces 'Lab Data as a Service'	12.04.
Ginkgo Bioworks Acquires AgBiome's Platform Assets	11.04.
Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets	11.04.
Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"	11.04.
Ginkgo Bioworks Expands Research Partnership With Novo Nordisk	10.04.
Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain	10.04.
Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks	10.04.
Ginkgo Bioworks Partners With IdeeLab Biotechnology in Brazil	08.04.
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service	08.04.
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service	08.04.
Ginkgo Bioworks to Host 5th Annual Ferment Conference	04.04.
Ginkgo Bioworks, Prozomix Collaborate on Enzyme Development	03.04.
Ginkgo Bioworks Acquires Modulus Therapeutics Cell Therapy Assets to Strengthen Next-Gen CAR Designs	03.04.
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing	03.04.
Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme Development for Sustainable API Manufacturing	03.04.
Ginkgo Bioworks (NYSE: DNA) completed the acquisition of cell therapy platform assets of Modulus Therapeutics.	02.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ginkgo Bioworks Holdings, Inc.

Aktien

A3C3B4

US37611X1000

DNA

Andere Sprachen

Filter